Added to YB: 2019-09-03
Pitch date: 2019-09-03
MRNA:US [bullish]
Moderna, Inc.
+228.92%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
Market Cap
$13.2B
Pitch Price
$15.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.33
P/E
-4.20
EV/Sales
3.27
Sector
Biotechnology
Category
N/A
Show full summary:
Moderna, Inc. MRNA:US
A summary for this pitch has not been created yet.
Read full article (0 min)